Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-11-17FDA Approved: OLMESARTAN MEDOXOMIL — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
FDA approved a supplemental application for olmesartan medoxomil from ScieGen Pharmaceuticals, enabling marketing of a generic product.
-
FDA approval · 2020-11-17FDA Approved: OLMESARTAN MEDOXOMIL — Supplemental Application (Lifestar Pharma LLC)
The FDA approved a supplemental application for olmesartan medoxomil from Lifestar Pharma LLC, granting approval for this antihypertensive g…
-
CLINICAL_TRIALS research · 2020-11-16Clinical Trial Update: Blood Pressure Checks for Diagnosing Hypertension (BP-CHECK) [NA]
Clinical trial update on using blood pressure checks for diagnosing hypertension; results posted after completion.
-
FDA approval · 2020-11-09FDA Approved: LABETALOL HYDROCHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved LABETALOL HYDROCHLORIDE (labetalol hydrochloride) from Hikma Pharmaceuticals USA Inc. under an Original Application. The dr…
-
CLINICAL_TRIALS trial_result · 2020-11-09Clinical Trial Update: Effect of Calcium- D Supplement on Hypertension [Phase 4]
Phase 4 clinical trial assessing the effect of Calcium-D supplement on hypertension has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-11-09Clinical Trial Update: Mindfulness Based Stress Reduction for High Blood Pressure [NA]
Clinical trial on mindfulness-based stress reduction for hypertension has completed with results posted in 2020.
-
FDA approval · 2020-11-06FDA Approved: METOPROLOL SUCCINATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved a generic version of metoprolol succinate (Camber Pharmaceuticals) under an Original Application (ANDA 205541).
-
FDA approval · 2020-11-03FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for a generic Benazepril hydrochloride and hydrochlorothiazide combination from Sandoz Inc.
-
FDA approval · 2020-11-03FDA Approved: NEBIVOLOL — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' original ANDA for Nebivolol, a generic beta-1 blocker indicated for hypertension.
-
CLINICAL_TRIALS trial_result · 2020-10-30Clinical Trial Update: Intensive Versus Standard Blood Pressure Lowering to Prevent Functional Decline in Older People [NA]
A completed clinical trial comparing intensive versus standard blood pressure lowering to prevent functional decline in older adults.
-
CLINICAL_TRIALS trial_result · 2020-10-29Clinical Trial Update: The Effects of the Dietary Supplement CardioFlex Q10 on Reducing Cardiovascular Disease Risk Factors in Adults [NA]
A completed clinical trial studying the effects of the dietary supplement CardioFlex Q10 on cardiovascular disease risk factors in adults.
-
CLINICAL_TRIALS trial_result · 2020-10-23Clinical Trial Update: THERAPY-HYBRID-BPA Trial [Phase 2]
Clinical trial update for THERAPY-HYBRID-BPA, a Phase 2 study sponsored by Okayama Medical Center.
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Losartan in Hypertensive Men and Women With Sleep Apnea Before and on Continuous Positive Airway Pressure (CPAP) Treatment [Phase 4]
Phase 4 clinical trial update evaluating losartan in hypertensive men and women with sleep apnea before and after CPAP treatment.
-
FDA approval · 2020-10-21FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Losartan Potassium by Aurobindo Pharma Limited under an ANDA.
-
CLINICAL_TRIALS research · 2020-10-20Clinical Trial Update: Connected Healthcare for Individuals Living at Home With Chronic Conditions [NA]
Clinical trial update describing connected healthcare for home-based management of chronic conditions; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Treatment of OSA Associated Hypertension With Nebivolol or Hydrochlorothiazide [Phase 4]
Phase 4 clinical trial comparing nebivolol vs hydrochlorothiazide for treatment of hypertension associated with obstructive sleep apnea has …
-
FDA approval · 2020-10-15FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)
The FDA approved the original application for Verapamil hydrochloride from Sagent Pharmaceuticals, establishing a generic version of this ca…
-
FDA approval · 2020-10-15FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original application for Verapamil hydrochloride from Zydus Pharmaceuticals USA Inc., confirming the generic formulation of…
-
FDA approval · 2020-10-13FDA Approved: AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for a fixed-dose combination tablet of amlodipine and benazepril hydrochloride by Rising Pharma Hold…
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: Study of the Cardiometabolic Effects of Obesity Pharmacotherapy [Phase 4]
Phase 4 clinical trial investigating cardiometabolic effects of obesity pharmacotherapy in obesity and hypertension populations.
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: Genetic Testing to Understand and Address Renal Disease Disparities [NA]
A completed clinical trial focused on genetic testing to understand and address disparities in renal disease among people with hypertension …
-
FDA approval · 2020-10-02FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for AZOR (amlodipine besilate and olmesartan medoxomil) submitted by Cosette Pharmaceuticals, In…
-
FDA approval · 2020-10-02FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for TRIBENZOR (olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide) submitted by Cosett…
-
FDA approval · 2020-09-30FDA Approved: LABETALOL HYDROCHLORIDE — Original Application (Epic Pharma, LLC)
FDA approved the original application for a generic labetalol hydrochloride product from Epic Pharma, LLC.
-
CLINICAL_TRIALS research · 2020-09-29Clinical Trial Update: The MHERO Study (Michigan's Hypertension, Diabetes, and Obesity Education Research Online) [Phase 1, Phase 2]
An early-stage (Phase 1/2) clinical trial called the MHERO Study conducted by the University of Michigan focusing on Type 2 diabetes mellitu…